HomeCompareTMOAF vs JNJ

TMOAF vs JNJ: Dividend Comparison 2026

TMOAF yields 27.62% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TMOAF wins by $95.3K in total portfolio value
10 years
TMOAF
TMOAF
● Live price
27.62%
Share price
$7.24
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$115.3K
Annual income
$14,197.29
Full TMOAF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TMOAF vs JNJ

📍 TMOAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTMOAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TMOAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TMOAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TMOAF
Annual income on $10K today (after 15% tax)
$2,348.07/yr
After 10yr DRIP, annual income (after tax)
$12,067.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TMOAF beats the other by $11,364.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TMOAF + JNJ for your $10,000?

TMOAF: 50%JNJ: 50%
100% JNJ50/50100% TMOAF
Portfolio after 10yr
$67.7K
Annual income
$7,512.54/yr
Blended yield
11.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TMOAF
No analyst data
Altman Z
1.5
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TMOAF buys
0
JNJ buys
0
No recent congressional trades found for TMOAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTMOAFJNJ
Forward yield27.62%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$115.3K$20.0K
Annual income after 10y$14,197.29$827.78
Total dividends collected$76.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TMOAF vs JNJ ($10,000, DRIP)

YearTMOAF PortfolioTMOAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,462$2,762.43$10,676$355.77+$2.8KTMOAF
2$17,880$3,475.61$11,407$389.39+$6.5KTMOAF
3$23,446$4,314.21$12,198$426.53+$11.2KTMOAF
4$30,375$5,287.05$13,056$467.62+$17.3KTMOAF
5$38,902$6,401.27$13,987$513.12+$24.9KTMOAF
6$49,287$7,662.05$14,998$563.56+$34.3KTMOAF
7$61,810$9,072.42$16,098$619.52+$45.7KTMOAF
8$76,770$10,633.15$17,295$681.69+$59.5KTMOAF
9$94,486$12,342.70$18,599$750.82+$75.9KTMOAF
10$115,297$14,197.29$20,022$827.78+$95.3KTMOAF

TMOAF vs JNJ: Complete Analysis 2026

TMOAFStock

TomTom N.V. develops and sells navigation and location-based products and services worldwide. The company operates in two segments, Location Technology and Consumer. It offers standard definition, advanced driver assistance system (ADAS), high definition (HD) maps, and map data, as well as places for map products; traffic and travel information products, including real-time traffic, hazard warning, speed camera, speed profile, road analytics, fuel and weather services, electric vehicle (EV) and parking services, and routing; and navigation products, such as navigation engine, traffic and travel information, navigation user interface, EV routing and range, and maps for automotive. The company also provides AutoStream, a solution that enables fast and efficient map delivery of the TomTom automated driving (AD) and ADAS Maps; RoadCheck, a tool for carmakers to determine when, where, and under what conditions their vehicles can safely activate AD functions; TomTom indigo, a digital cockpit platform; and virtual horizon products. In addition, it offers road analytics solutions, including traffic stats, origin destination analysis, route monitoring, road event reporter, and junction analytics; and shop products, such as navigation devices, accessories, and map updates, as well as support services. The company serves the automotive, fleet management and logistics, mobility and on-demand, road traffic management, and location intelligence industries. TomTom N.V. was founded in 1991 and is headquartered in Amsterdam, the Netherlands.

Full TMOAF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TMOAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TMOAF vs SCHDTMOAF vs JEPITMOAF vs OTMOAF vs KOTMOAF vs MAINTMOAF vs ABBVTMOAF vs MRKTMOAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.